Nobel Prize Honors Groundbreaking Body's Defenses Research
This year's Nobel Prize in medical science was granted for transformative findings that illuminate how the immune system attacks dangerous infections while protecting the body's own cells.
Three esteemed researchers—Japan's Prof. Sakaguchi and US scientists Mary Brunkow and Dr. Ramsdell—received this honor.
Their work identified specialized "sentinels" within the defense system that remove malfunctioning immune cells capable of harming the body.
These discoveries are now paving the way for innovative therapies for autoimmune diseases and cancer.
These winners will divide a monetary award valued at 11 million Swedish kronor.
Crucial Findings
"Their research has been essential for comprehending how the body's defenses operates and why we do not all suffer from serious self-attack conditions," stated the head of the award panel.
This team's research explain a fundamental mystery: In what way does the defense system defend us from numerous infections while keeping our own tissues unharmed?
Our immune system employs immune cells that search for indicators of disease, including pathogens and germs it has not met before.
Such defenders employ sensors—called recognition units—that are generated randomly in a vast number of combinations.
That provides the defense network the capacity to combat a wide array of threats, but the unpredictability of the mechanism inevitably produces white blood cells that may attack the body.
Security Guards of the Body
Scientists earlier knew that a portion of these harmful defense cells were eliminated in the thymus—where white blood cells develop.
The latest award recognizes the discovery of regulatory T-cells—known as the immune system's "peacekeepers"—which travel through the body to neutralize any immune cells that attack the healthy cells.
It is known that this mechanism fails in self-attack conditions such as type-1 diabetes, multiple sclerosis, and RA.
A prize committee stated, "The findings have established a novel area of investigation and spurred the development of innovative treatments, for example for tumors and autoimmune diseases."
Regarding cancer, regulatory T-cells block the system from attacking the tumor, so research are focused on reducing their quantity.
For autoimmune diseases, trials are exploring boosting T-reg cells so the organism is no longer under attack. A comparable method could also be effective in reducing the risks of organ transplant failure.
Pioneering Experiments
Professor Shimon Sakaguchi, of a Japanese institution, conducted tests on rodents that had their immune gland extracted, causing autoimmune disease.
He showed that injecting defense cells from other animals could prevent the disease—suggesting there was a system for blocking immune cells from harming the host.
Dr. Brunkow, from the Institute for Systems Biology in Seattle, and Fred Ramsdell, currently at Sonoma Biotherapeutics in a California city, were investigating an genetic immune disorder in mice and people that resulted in the discovery of a genetic factor vital for how regulatory T-cells operate.
"The groundbreaking research has revealed how the body's defenses is kept in check by regulatory T cells, stopping it from mistakenly targeting the healthy cells," commented a prominent physiology expert.
"This research is a striking example of how basic physiological study can have far-reaching consequences for public health."
